According to the recent analysis by ChemAnalyst, in the South Korean Metformin HCL market prices saw a significant dip in April xxxx, moving in the opposite direction of the price levels that were observed in March xxxx. The price drop was mainly because of an oversupplied international market, cheaper imports, and waning domestic demand.
Prices for Metformin HCL in South Korea declined in April xxxx, breaking the upward price trend observed in March, due to strong global availability along with lower costs of imports.
South Korean buyers purchased Metformin HCL at lower prices due to Chinese exporters&#xx; decreasing selling prices in the face of industrial deflation and over-supply.
South Korean high inventories and low manufacturing activity negatively impacted Metformin HCL’s procurement momentum over the month leading to lower purchases.
While Metformin continued...
